Zimmer Biomet Holdings, Inc.
ZBHNYSECIK 1136869HealthcareFiscal year ends Dec 31
Reports and events: 333 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0820:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385256 |
| 2026-08-0520:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-335108 |
| 2026-08-0520:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335044 |
| 2026-08-0510:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333761 |
| 2026-06-2920:02 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-288390 |
| 2026-05-2721:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-242207 |
| 2026-05-1210:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-218098 |
| 2026-05-0121:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-201710 |
| 2026-04-2810:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-183430 |
| 2026-04-2810:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-183411 |
| 2026-04-0111:00 ET | DEF 14A | Proxy statementPeriod 2026-05-22 | 0001193125-26-135661 |
| 2026-02-2023:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-059853 |
| 2026-02-1011:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-043620 |
| 2026-01-1214:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-009895 |
| 2025-11-0521:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266884 |
| 2025-11-0511:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265649 |
| 2025-10-0720:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-233473 |
| 2025-09-0420:15 ET | 8-K | 8.01 Other events | 0001193125-25-196060 |
| 2025-08-0720:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104989 |
| 2025-08-0710:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104527 |
| 2025-07-1520:57 ET | SCHEDULE 13D | Ownership report, active investor | 0000950170-25-095910 |
| 2025-07-1411:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158442 |
| 2025-06-3020:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-152694 |
| 2025-06-0311:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-080567 |
| 2025-05-2711:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-126231 |
| 2025-05-0520:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063509 |
| 2025-05-0510:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063124 |
| 2025-04-2120:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-087219 |
| 2025-04-1411:00 ET | DEF 14A | Proxy statementPeriod 2025-04-09 | 0000950170-25-053494 |
| 2025-02-2521:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-035147 |
| 2025-02-2521:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026604 |
| 2025-02-1921:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-029614 |
| 2025-02-1821:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-028618 |
| 2025-02-0611:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-014972 |
| 2025-01-2911:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-014881 |
| 2025-01-2923:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-014569 |
| 2024-11-2021:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-262540 |
| 2024-11-1921:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-261733 |
| 2024-10-3020:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-118959 |
| 2024-10-3010:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-118573 |
| 2024-08-1520:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-201328 |
| 2024-08-1420:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-200634 |
| 2024-08-0721:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-092996 |
| 2024-08-0720:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092746 |
| 2024-08-0710:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092253 |
| 2024-07-0120:17 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-173303 |
| 2024-06-2011:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-075310 |
| 2024-05-1521:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-060580 |
| 2024-05-0220:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052097 |
| 2024-05-0210:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051551 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.